- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carcinoma, Transitional Cell
Total 43426 results
-
AnchorDx Medical Co., Ltd.Peking University First Hospital; Peking Union Medical College Hospital; Peking... and other collaboratorsRecruitingUpper Tract Urothelial CarcinomaChina
-
Association Pour La Recherche des Thérapeutiques...Active, not recruitingInfiltrating Bladder Urothelial CarcinomaFrance
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingUpper Tract Urothelial CarcinomaUnited States
-
RenJi HospitalUnknown
-
Jonsson Comprehensive Cancer CenterUroGen Pharma Ltd.No longer availableUrothelial Carcinoma Ureteral LocationUnited States
-
Tata Memorial CentreNot yet recruitingNon-Invasive Bladder Urothelial Carcinoma
-
YULISUOno Pharmaceutical Co. LtdRecruitingUpper Urinary Tract Urothelial CarcinomaTaiwan
-
Associació per a la Recerca Oncologica, SpainTakeda; Pivotal S.L.Unknown
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedTransitional Cell Carcinoma | Bladder CancerItaly
-
University of British ColumbiaCanadian Urologic Oncology GroupCompletedTransitional Cell Carcinoma | Bladder CancerCanada
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnTransitional Cell Carcinoma | Infiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma
-
Jinling Hospital, ChinaRecruitingCarcinoma | Upper Tract Urothelial Carcinoma | UTUCChina
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Bladder Carcinoma | Metastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Metastatic Transitional Cell CarcinomaUnited States
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Incyte CorporationCompletedUC (Urothelial Cancer)United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Metastases, NeoplasmUnited States
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Cancer | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder Cancer | Localized Transitional Cell Cancer... and other conditions
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Urothelial Carcinoma | Urothelial NeoplasmsAustralia, United States, Canada, Chile, France, Israel, Italy, Korea, Republic of, Netherlands, Spain, Taiwan, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
Xiangya Hospital of Central South UniversityHunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaboratorsCompletedHigh-Grade Upper Tract Urothelial CarcinomaChina
-
Ruijin HospitalHangzhou Genetron Medical Laboratory Co., Ltd.Recruiting
-
Inovio PharmaceuticalsActive, not recruitingUrothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknown
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Urothelial CarcinomaChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
UNICANCERCompletedKRAS Gene Mutation | Infiltrating Urothelial CarcinomaFrance
-
Fox Chase Cancer CenterRecruitingUrothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingUpper Excretory Tract Tumors
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingUrothelial CarcinomaHungary, United States, Argentina, Australia, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Nabil AdraGenentech, Inc.; Indiana University School of MedicineTerminated
-
Merck Sharp & Dohme LLCActive, not recruitingUrothelial CarcinomaAustralia, United States, Chile, Denmark, Israel, Korea, Republic of, Spain
-
ImmunityBio, Inc.Withdrawn
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Seagen Inc.Not yet recruitingRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Asan Medical CenterKorean Cancer Study GroupUnknownTransitional Cell Carcinoma | Bladder Cancer | Ureter CancerKorea, Republic of
-
Altor BioScienceNational Cancer Institute (NCI)CompletedTransitional Cell Carcinoma of Bladder | Urethra Cancer | Ureter Cancer | Malignant Tumor of Renal PelvisUnited States
-
Taiho Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced and Metastatic Urothelial CancerSpain, United States, France
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingMetastatic Urothelial CarcinomaChina
-
Shanghai Miracogen Inc.RecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial CancerChina
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
King Faisal Specialist Hospital & Research CenterCompleted